HomeNewsOpinionChina’s insecurities have played out in Ladakh

China’s insecurities have played out in Ladakh

It is no secret that the growing Chinese belligerence along the LAC owes in large part to Beijing’s exaggerated jitters at India’s efforts to build logistical infrastructure in the region

October 10, 2020 / 18:18 IST
Story continues below Advertisement

As Indian and Chinese border troops in eastern Ladakh stare each other down in the biggest military confrontation in over 50 years, an uneasy world is looking for signs of de-escalation of the conflict. The tragic violence on June 15 saw soldiers of China’s People’s Liberation Army (PLA) attacking and killing at least 20 Indian soldiers, including a colonel. Although the number of Chinese casualties in the carnage is not known, scores of PLA soldiers are reported to have been killed and many injured.

Minor skirmishes on the 3,400-km-long disputed India-China border are not uncommon. Nevertheless, there were clear signs of Chinese mal-intent since April when unusually large numbers of PLA troops crossed the Line of Actual Control (LAC) into the Galwan and Pangong Tso areas. This was not exactly temporary squatting on disputed land either, as had happened several times over the years. The Chinese now seemed to be digging in for the long haul, with bunkers and artillery guns covering its troop deployment right under the nose of the Indian Army.

Story continues below Advertisement

So was India caught off guard in the mountainous border region by its eastern neighbour’s deadly game of Chinese checkers? Unfortunately, there is little evidence to suggest otherwise.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show